| Financial Year |
March 31 2023 |
| Monetary Funds |
312,950,200.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
60,310,595.00 |
| Accounts Receivable |
721,561,979.64 |
| Advances to Suppliers |
87,766,046.03 |
| Other Receivables |
39,471,963.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
769,371,400.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
57,423,430.05 |
| Total Current Assets |
2,072,466,796.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
591,244,884.43 |
| Investment Properties |
7,495,225.30 |
| Fixed Assetes |
1,537,070,800.28 |
| Under-construction Projects |
96,798,269.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
315,797,632.99 |
| R&D expenses |
-- |
| Goodwill |
67,813,353.73 |
| Long-Term Deferred and Prepaid Expenses |
63,436,899.68 |
| Deferred Income Tax Assets |
187,166,656.49 |
| Other Non-Current Assets |
23,471,441.05 |
| Sub-Total of Non-Current Assets |
3,044,242,562.60 |
| Total Assets |
5,116,709,358.67 |
| Short-Term Loans |
1,146,689,747.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
204,018,436.68 |
| Accounts Payable |
480,169,882.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
64,843,807.25 |
| Taxes Payable |
26,900,134.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
50,672,459.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
41,729,602.65 |
| Other Current Liabilities |
66,903,895.45 |
| Sub-Total of Current Liabilities |
2,240,884,872.80 |
| Long-term Loans |
375,067,594.78 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
22,396,031.92 |
| Deferred Income Tax Liabilities |
64,239,192.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
868,110,664.08 |
| Total Liabilities |
3,108,995,536.88 |
| Paid-In Capital(Or Share Stock) |
340,638,579.00 |
| Capital Surplus |
1,027,805,175.18 |
| Surplus Reserve |
124,424,189.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
529,652,268.62 |
| Minority Stockholder's Interest |
-8,999,013.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,016,712,834.80 |
| Owner's Equity（Stockholder's Equity） |
2,007,713,821.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,116,709,358.67 |
